Comparison of the BBL-mycobacteria growth indicator tube method with culture in the diagnosis of tuberculosis and evaluation of the resistance patterns of isolated strains to four major drugs

dc.contributor.author Kocazeybek, Bekir Sami
dc.date.accessioned 2019-06-27T08:01:01Z
dc.date.available 2019-06-27T08:01:01Z
dc.date.issued 2002
dc.description.abstract The BBL-mycobacteria growth indicator tube system (MGIT) is used for a rapid detection of the presence of mycobacteria. Our study aimed to compare MGIT with the Lowenstein-Jensen (LJ) reference method in clinical samples with suspected pulmonary and extrapulmonary tuberculosis and to evaluate the primary and secondary resistance patterns by determining the resistances of the isolated strains to four major anti mycobacteria I drugs. 648 clinical samples from different clinics with suspected pulmonary or extrapulmonary tuberculosis based on clinical radiological histopathological and immunological findings were included in the investigation. The samples were first stained with Ziehl-Neelsen (ZN) and then cultured in LJ medium according to the standard bacteriological procedure and in the MGIT as recommended by the manufacturer. Conventional biochemical tests and p-nitro-alpha-acethylamino-beta-hydroxypropiophene of the Bactec system were used to identify the isolated mycobacterial strains. The susceptibilities to streptomycin isoniazid rifampicin ethambutol were tested by the BBL-MGIT antibiotic susceptibility test and the resistances of the strains found to be resistant to any of the drugs were confirmed by the agar proportion method. Mycobacterium spp. were isolated in 61 (9.4%) out of 648 samples. Eventually 58 out of 61 strains were classified as Mycobacterium tuberculosis and the other 3 as Mycobacterium tuberculosis complex. 32 of these were ZN positive. The growth time was determined as 12.2 days by the MGIT method and 24.1 days by the LJ method (p < 0.001). 29 strains were ZN negative. Their growth time was 23 days by the MGIT method and 37 days by the LJ method (p < 0.001). Drug resistance was detected in 23 (37.7%) of 61 cases (of whom 39 were new and 22 were former patients) en_US]
dc.description.abstract of these resistances 8 (20.51%) were primary and 15 (68.18%) were secondary. In double drug resistance secondary resistance was found only to isoniazid + rifampin (4 cases) whereas both primary and secondary resistances were found to one drug. The highest cumulative drug resistance - both primary and secondary - was found to isoniazid. In conclusion the MGIT was found to be advantageous because it enables rapid bacterial identification of tuberculosis and detection of antimicrobial resistance due to its high sensitivity and specificity. It is quicker than the LJ method. Its antibiotic susceptibility can be tested and it is easy to perform. We recommend to include it in routine laboratory work. In addition our study suggests that the high ratio of secondary resistance in the public might be related to inappropriate and insufficient treatment of tuberculosis and noncompliance which appear to cause an important increase in primary tuberculosis as a result of new contaminations. Copyright (C) 2002 S. Karger AG Basel. en_US]
dc.identifier.doi 10.1159/000057664 en_US
dc.identifier.issn 0009-3157 en_US
dc.identifier.issn 0009-3157
dc.identifier.issn 1421-9794
dc.identifier.scopus 2-s2.0-0036249277 en_US
dc.identifier.uri https://hdl.handle.net/20.500.12469/216
dc.identifier.uri https://doi.org/10.1159/000057664
dc.language.iso en en_US
dc.publisher Karger en_US
dc.relation.ispartof Chemotherapy
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Mycobacterium tuberculosis en_US
dc.subject Mycobacteria growth indicator tube system en_US
dc.subject Drug resistance en_US
dc.title Comparison of the BBL-mycobacteria growth indicator tube method with culture in the diagnosis of tuberculosis and evaluation of the resistance patterns of isolated strains to four major drugs en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.institutional Kocazeybek, Bekir Sami en_US
gdc.bip.impulseclass C5
gdc.bip.influenceclass C4
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.endpage 70
gdc.description.issue 2
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage 64 en_US
gdc.description.volume 48 en_US
gdc.description.wosquality Q3
gdc.identifier.openalex W2028072903
gdc.identifier.pmid 12011537 en_US
gdc.identifier.wos WOS:000175869400002 en_US
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 3.3638272E-9
gdc.oaire.isgreen false
gdc.oaire.keywords Population Dynamics
gdc.oaire.keywords Antitubercular Agents
gdc.oaire.keywords Drug Resistance, Microbial
gdc.oaire.keywords Mycobacterium tuberculosis
gdc.oaire.keywords Sensitivity and Specificity
gdc.oaire.keywords Mycobacterium
gdc.oaire.keywords Reference Values
gdc.oaire.keywords Drug resistance
gdc.oaire.keywords Humans
gdc.oaire.keywords Tuberculosis
gdc.oaire.keywords Mycobacteria growth indicator tube system
gdc.oaire.popularity 5.4488347E-10
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 0303 health sciences
gdc.oaire.sciencefields 03 medical and health sciences
gdc.openalex.collaboration International
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.1
gdc.opencitations.count 6
gdc.plumx.crossrefcites 2
gdc.plumx.mendeley 11
gdc.plumx.pubmedcites 1
gdc.plumx.scopuscites 7
gdc.relation.journal Chemotherapy
gdc.scopus.citedcount 7
gdc.wos.citedcount 6
relation.isOrgUnitOfPublication b20623fc-1264-4244-9847-a4729ca7508c
relation.isOrgUnitOfPublication.latestForDiscovery b20623fc-1264-4244-9847-a4729ca7508c

Files